MDL Panel Grants Transfer Of Aflibercept BPCIA Case - Patent

As we previously reported, on January 11, 2024, Regeneron Pharmaceuticals, Inc. ("Regeneron") moved to establish a multi-district litigation ("MDL") for its aflibercept BPCIA litigation...

Related Keywords

West Virginia , United States , Northern District , Virginia , California , Mylan Biocon , Samsung Bioepis , Thomass Kleeh , Samsung , Regeneron Pharmaceuticals Inc , Amgen , Amgen Inc , Judicial Panel On Multidistrict , Regeneron Pharmaceuticals , Chief Judge Thomas , Judicial Panel , Judge Kleeh , Big Molecule Watch ,